Beijing Tiantan Biological Products Corp Ltd (600161) — Net Asset Quality Index

Latest as of September 2025: 90.3%

Beijing Tiantan Biological Products Corp Ltd (600161) has a Net Asset Quality Index of 90.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥16.55 Billion minus total liabilities of CN¥1.60 Billion yields net assets of CN¥14.95 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 600161 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

90.3%
Equity / Total Assets

Net Assets

CN¥14.95 Billion
CNY

Total Assets

CN¥16.55 Billion
CNY

Total Liabilities

CN¥1.60 Billion
CNY

Beijing Tiantan Biological Products Corp Ltd Net Asset Quality Index Over Time (1995–2024)

This chart shows how Beijing Tiantan Biological Products Corp Ltd's Net Asset Quality Index has evolved across 30 annual periods from 1995 to 2024. As of September 2025, the index stands at 90.3%, representing net assets of CN¥14.95 Billion against total assets of CN¥16.55 Billion CNY. See how liquid is Beijing Tiantan Biological Products Corp's working capital to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Beijing Tiantan Biological Products Corp Ltd (1995–2024)

The table below presents the year-by-year Net Asset Quality Index for Beijing Tiantan Biological Products Corp Ltd from 1995 to 2024, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Beijing Tiantan Biological Products Corp market cap and net worth.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 91.6% CN¥14.53 Billion CN¥15.87 Billion CN¥1.34 Billion ▲ +1.7 pp
2023 89.9% CN¥12.75 Billion CN¥14.19 Billion CN¥1.43 Billion ▲ +2.1 pp
2022 87.8% CN¥11.36 Billion CN¥12.94 Billion CN¥1.58 Billion ▼ -0.9 pp
2021 88.7% CN¥10.27 Billion CN¥11.58 Billion CN¥1.31 Billion ▲ +8.7 pp
2020 80.0% CN¥6.03 Billion CN¥7.54 Billion CN¥1.51 Billion ▼ -2.0 pp
2019 82.0% CN¥5.18 Billion CN¥6.31 Billion CN¥1.14 Billion ▼ -3.8 pp
2018 85.8% CN¥4.35 Billion CN¥5.07 Billion CN¥720.19 Million ▼ -1.1 pp
2017 86.9% CN¥3.18 Billion CN¥3.67 Billion CN¥481.46 Million ▲ +44.7 pp
2016 42.2% CN¥2.44 Billion CN¥5.78 Billion CN¥3.34 Billion ▲ +2.5 pp
2015 39.7% CN¥2.24 Billion CN¥5.63 Billion CN¥3.40 Billion ▲ +2.8 pp
2014 36.9% CN¥2.22 Billion CN¥6.02 Billion CN¥3.80 Billion ▼ -1.8 pp
2013 38.6% CN¥2.18 Billion CN¥5.63 Billion CN¥3.46 Billion ▲ +1.6 pp
2012 37.0% CN¥1.78 Billion CN¥4.81 Billion CN¥3.03 Billion ▼ -7.9 pp
2011 44.9% CN¥1.45 Billion CN¥3.22 Billion CN¥1.78 Billion ▼ -1.8 pp
2010 46.7% CN¥1.14 Billion CN¥2.45 Billion CN¥1.31 Billion ▲ +2.7 pp
2009 43.9% CN¥949.13 Million CN¥2.16 Billion CN¥1.21 Billion ▼ -19.4 pp
2008 63.3% CN¥756.97 Million CN¥1.20 Billion CN¥439.35 Million ▼ -3.0 pp
2007 66.3% CN¥725.57 Million CN¥1.09 Billion CN¥369.34 Million ▼ -0.3 pp
2006 66.5% CN¥708.35 Million CN¥1.06 Billion CN¥356.20 Million ▼ -12.3 pp
2005 78.8% CN¥669.09 Million CN¥848.76 Million CN¥179.67 Million ▼ -4.7 pp
2004 83.5% CN¥636.79 Million CN¥762.49 Million CN¥125.70 Million ▲ +4.5 pp
2003 79.0% CN¥599.70 Million CN¥758.95 Million CN¥159.24 Million ▲ +21.8 pp
2002 57.3% CN¥289.04 Million CN¥504.77 Million CN¥215.73 Million ▼ -5.3 pp
2001 62.5% CN¥289.68 Million CN¥463.32 Million CN¥173.64 Million ▼ -0.1 pp
2000 62.6% CN¥279.21 Million CN¥445.98 Million CN¥166.77 Million ▼ -1.0 pp
1999 63.6% CN¥279.67 Million CN¥439.55 Million CN¥159.88 Million ▼ -6.6 pp
1998 70.3% CN¥265.80 Million CN¥378.34 Million CN¥112.54 Million ▲ +11.5 pp
1997 58.7% CN¥92.37 Million CN¥157.25 Million CN¥64.88 Million ▲ +13.6 pp
1996 45.2% CN¥60.19 Million CN¥133.25 Million CN¥73.06 Million ▼ -2.6 pp
1995 47.8% CN¥59.67 Million CN¥124.85 Million CN¥65.18 Million —
pp = percentage points